EXHIBIT 5
JOINT FILING AGREEMENT
Each of the undersigned represents that he, she or it is eligible to use
Schedule 13D to report his, her or its beneficial ownership (as defined in Rule
13d-3 promulgated under the Securities Exchange Act of 1934, as amended (the
"Exchange Act")) of common stock, par value $.001 per share ("Common Stock"), of
Inverness Medical Innovations, Inc., a Delaware corporation ("Innovations").
Each of the undersigned agrees:
1. that he, she or it is responsible for the timely filing of, a Schedule
13D, and any amendments thereto (the "Schedule 13D"), with respect to
his, her or its beneficial ownership reporting obligations with
respect to the Common Stock;
2. that he, she or it is responsible for the completeness and accuracy of
the information concerning him, her or it contained in the Schedule
13D, but is not responsible for the completeness or accuracy of the
information concerning any other persons or entities making the
filing, unless he, she or it knows or has reason to believe that such
information is inaccurate; and
3. in accordance with Rule 13d-1(k)(1) promulgated under the Exchange
Act, to the joint filing with each of the other persons or entities
executing this joint filing agreement (this "Agreement"), on behalf of
each of them, of the Schedule 13D (including all amendments thereto)
and that this Agreement be included as an exhibit to the Schedule 13D.
This Agreement may be executed in any number of counterparts, each of which
shall be deemed to be an original, but all of which, taken together, shall
constitute one and the same instrument.
[Remainder of page intentionally left blank]
IN WITNESS WHEREOF, the undersigned have caused this Agreement to be signed
as of June 6, 2002.
/s/ Xxx Xxxxxxxxx
-------------------------------------
Xxx Xxxxxxxxx
/s/ Xxxxx X. Xxxxxxxxx
-------------------------------------
Xxxxx X. Xxxxxxxxx
XXXXXXXXX FAMILY VENTURES, LLC
By: /s/ Xxx Xxxxxxxxx
----------------------------------
Xxx Xxxxxxxxx
Manager
